VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 2 | -100.0% | 0.00% | – |
| Q2 2022 | $25,000 | -13.8% | 28,500 | +23.4% | 0.00% | – |
| Q1 2022 | $29,000 | -29.3% | 23,096 | +56.1% | 0.00% | -100.0% |
| Q3 2021 | $41,000 | -87.1% | 14,800 | -85.3% | 0.00% | -75.0% |
| Q2 2021 | $317,000 | +51.7% | 100,656 | +2.4% | 0.00% | +33.3% |
| Q1 2021 | $209,000 | +450.0% | 98,290 | +399.2% | 0.00% | +200.0% |
| Q4 2020 | $38,000 | – | 19,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |